Answers are grounded in this paper and cite their sources.
Evaluates the antimicrobial effectiveness of synthesized copper oxide nanostructures in various microorganisms, suggesting its potential use in medicine.
In current study, the morphology of copper (II) oxide nano-material was evaluated using, ethylene diamminetetraacetate as soft template via low temperature aqueous chemical growth technique. Scanning Electron Microscopy (SEM) was used to investigate the morphology of copper (II) oxide nanostructures and freshly developed CuO was observed to have spherical shape. X-ray Diffraction (XRD) method was used to study the crystalline quality of cuperic oxide which showed crystalline nature of high quality. Three types of bacteria and one type of fungi were selected to facilitate the antimicrobial activity of synthesized nanostructures. In this work it was declared that as concentration of CuO increases the inhibition zone also increases for all the three types of bacteria and fungi too. At the concentration of 1.0mg/L the inhibition zone found was as given below: pergillusniger>15.41mm, Agrobacterium tumefaciens> 21.5mm, Klebsiella pneumonia >23.6mm and E.coli>28.6mm. It was further found that E. coli was extra responsive to copper oxide. published by the Journal of Biodiversity and Environmental Sciences | JBES
No takes yet. Share an insight, caveat, or question.
Bahou Laurent (2021) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: